Alexandria Investments is the corporate venture capital platform associated with Alexandria, based in Cambridge, MA. It invests across the United States in life sciences companies advancing new modalities, platforms and innovative medicines, with a focus on biotechnology and pharmaceuticals. The platform backs seed, early-stage and growth-stage companies and provides select LaunchLabs member companies with access to capital. It reports about $1.5B in venture investments, with notable early investments including Alnylam Pharmaceuticals, Google and Intra-Cellular Therapies.